BLOG: MOCA-funded research for early detection test advances to DOD funding

BLOG: MOCA-funded research for early detection test advances to DOD funding


2.16.16 Since MOCA was founded, we’ve provided more than $5 million to ovarian cancer research funding. This has gone to researchers at the University of Minnesota and Mayo Clinic, dedicated to getting us closer to an early detection test, better treatments and – one day – a cure for ovarian cancer.

We’re excited to share the news that one of MOCA’s most-funded researchers – Dr. Amy Skubitz at the University of Minnesota has recently been awarded a Department of Defense research award. Dr. Skubitz has been funded by MOCA several times in the past years – totaling close to $1 million.

Dr. Skubitz will be receiving a 2-year, $250,000 award from the Department of Defense Ovarian Cancer Research Program to further her research on using PAP tests to screen for ovarian cancer. MOCA funding started this promising research project over the past several years and it is exciting news to see it move to the next level.

We asked Dr. Skubitz to tell MOCA supporters about the importance of this award – and what it could mean to early detection for ovarian cancer.

In Dr. Skubitz’s words:

“The initial funding that I received from MOCA allowed me to pursue a research project for which I had only limited data.  MOCA and I share the same goal: To develop a test for the early detection of ovarian cancer. 

I am so grateful to MOCA for their willingness to financially support my high-risk project in its earliest stages.

MOCA’s funding enabled me to hire personnel to work in the clinic and enlist women for our “Mock Pap tests”.  I was able to hire personnel with expertise in biochemistry and proteomics, as well as perform the very expensive mass spectrometry analysis.  After relying upon MOCA for 3 years of funding, I am pleased to say that we were able to generate high quality data in order to garnish funding from the DOD for a Pilot Award.

I am very optimistic about the impact that our study will have for women with ovarian cancer.”

Stay tuned for further updates on this and other MOCA-funded research projects. MOCA can’t fund this vital research – bringing us closer to an early detection test and better treatments – without your help. Please, consider a gift to help us continue this important work by giving now.